RN7SL815P

Across TCGA pan-cancer cohorts, RN7SL815P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RN7SL815P data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RN7SL815P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL815P expression acts as an unfavorable survival marker.

READ, LUSC, and THCA are the cancer types where RN7SL815P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	All	0.384	0.726	<.001	108	view →
LUSC	DFS	Tertile	III,IV	0.105	0.823	<.001	54	view →
THCA	OS	Tertile	IV	0.579	1.000	<.001	42	view →
LUAD	DFS	Tertile	IV	0.045	0.717	<.001	36	view →
CESC	OS	Tertile	IV	0.091	0.593	<.001	36	view →
COAD	DFS	Tertile	IV	0.035	0.501	<.001	36	view →
KICH	DFS	Tertile	II,III,IV	0.417	0.907	.009	19	view →
DLBC	DFS	Tertile	IV	0.120	0.683	.001	18	view →
ESCA	DFS	Tertile	All	0.254	0.806	.018	15	view →
TGCT	DFS	Tertile	All	0.627	0.849	.028	12	view →
LIHC	OS	Tertile	III,IV	0.213	0.648	.042	9	view →
STAD	DFS	Quartile	II,III,IV	0.390	0.565	.022	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RN7SL815P–READ (DFS)

Open the READ breakdown →